JP2011057578A - Peroxide lipid inhibitor and skin external preparation - Google Patents

Peroxide lipid inhibitor and skin external preparation Download PDF

Info

Publication number
JP2011057578A
JP2011057578A JP2009206601A JP2009206601A JP2011057578A JP 2011057578 A JP2011057578 A JP 2011057578A JP 2009206601 A JP2009206601 A JP 2009206601A JP 2009206601 A JP2009206601 A JP 2009206601A JP 2011057578 A JP2011057578 A JP 2011057578A
Authority
JP
Japan
Prior art keywords
external preparation
tea extract
acne
derivative
skin external
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009206601A
Other languages
Japanese (ja)
Inventor
Hitomi Hase
仁美 長谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2009206601A priority Critical patent/JP2011057578A/en
Publication of JP2011057578A publication Critical patent/JP2011057578A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a peroxide lipid inhibitor and a skin external preparation which have a high effect, particularly an acne skin external preparation effective for preventing and improving acne since the effect of inhibiting the formation of peroxide lipid by vitamin C or a derivative thereof alone is insufficient and the effect on acne or the like caused by the formation of the peroxide lipid could not have been expected. <P>SOLUTION: An excellent peroxide lipid inhibitor, skin external preparation, and particularly acne skin external preparation can be obtained by using vitamin C or a derivative thereof in combination with sweet tea and/or a tea extract. By further using vitamin C or a derivative thereof and sweet tea and/or a tea extract in combination with a green tea extract, an excellent peroxide lipid inhibitor and skin external preparation, particularly, acne skin external preparation can be obtained. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

本発明は、ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物、さらに緑茶抽出物を含有することを特徴とする、過酸化脂質抑制剤及び皮膚外用剤、特にアクネ用皮膚外用剤に関する。     The present invention relates to a lipid peroxide inhibitor and a skin external preparation, particularly an acne skin external preparation, characterized in that it contains vitamin C or a derivative thereof, strawberry tea and / or black tea extract, and further green tea extract.

皮膚は、身体の最外層に位置し、外部環境から生体内部を保護すると共に、生体の恒常性を維持するために重要な役割を担っている。そのため皮膚は日常生活で受ける紫外線やその他の種々の酸化ストレスによって何らかの影響を受けている。特に皮脂は容易に酸化され、過酸化脂質が生成する。この過酸化反応が様々な肌の変調(ニキビ、吹き出物、肌荒れ、乾燥肌、しわ、シミ、くすみ等)の要因になる。     Skin is located in the outermost layer of the body and plays an important role in protecting the living body from the external environment and maintaining the homeostasis of the living body. Therefore, the skin is affected in some way by ultraviolet rays and other various oxidative stresses received in daily life. In particular, sebum is easily oxidized and lipid peroxide is generated. This peroxidation reaction causes various skin modulations (acne, pimples, rough skin, dry skin, wrinkles, spots, dullness, etc.).

これまでに、ニキビを予防したり、悪化させないように抑えたり、症状を改善したりするために、1.皮脂分泌を抑制する成分を含むもの:ヒドロキシフルタミドを有効成分として含有することを特徴とする皮脂抑制剤(特許文献1参照)、2.毛穴を塞いでいる角栓を除去する成分を含むもの:ステロイドサポニンを有効成分とする角層剥離促進剤・ニキビ予防治療剤(特許文献2参照)、3.にきびを刺激して悪化させるにきび桿菌などの皮膚常在菌が増えないようにする成分を含むもの:キチンオリゴ糖、キチン若しくはその部分分解物、又はキトサンオリゴ糖、キトサン若しくはその部分分解物を有効成分として配合してなることを特徴とするにきび用化粧料(特許文献3参照)、4.ニキビの炎症を抑える成分を含むもの:グリチルリチン酸ジカリウム、グリチルレチン酸ステアリル、β−グリチルレチン酸及びステアリン酸グリチルレチニルから選ばれる抗炎症剤を含有する皮膚外用剤(特許文献4参照)等が開示されている。     To prevent acne, prevent it from getting worse, and improve symptoms so far: 1. A component containing a component that suppresses sebum secretion: a sebum inhibitor characterized by containing hydroxyflutamide as an active component (see Patent Document 1). 2. A component containing a component that removes a horn plug that closes the pores: a stratum corneum peeling promoter / acne preventive and therapeutic agent containing steroid saponin as an active ingredient (see Patent Document 2). Ingredients that prevent acne-causing fungi and other skin resident bacteria from increasing by stimulating acne: Contains chitin oligosaccharides, chitin or partial degradation products thereof, or chitosan oligosaccharides, chitosan or partial decomposition products effective 3. Acne cosmetics characterized by being blended as an ingredient (see Patent Document 3). Contains an ingredient for suppressing acne inflammation: a topical skin preparation containing an anti-inflammatory agent selected from dipotassium glycyrrhizinate, stearyl glycyrrhetinate, β-glycyrrhetinic acid and glycyrrhetinyl stearate (see Patent Document 4), etc. .

また、脂漏症およびそれに関連する皮膚病、特にアクネを処理するための活性剤としてアスコルビン酸を使用することが知られている(特許文献5参照)。しかしながら、ビタミンCまたはその誘導体での過酸化脂質の生成を抑制することは、不十分であった。     It is also known to use ascorbic acid as an active agent for treating seborrhea and related skin diseases, particularly acne (see Patent Document 5). However, inhibiting the production of lipid peroxides with vitamin C or its derivatives has been insufficient.

特開平6−157242号公報JP-A-6-157242 特許第4173719号公報Japanese Patent No. 4173719 特許第3253982号公報Japanese Patent No. 32533982 特許第4011802号公報Japanese Patent No. 4011802 特開平9−110628号公報JP-A-9-110628

ビタミンCまたはその誘導体単独での過酸化脂質の生成を抑制する効果は不十分であり、過酸化脂質が生成することによって惹起されるニキビ等に対する効果は期待できなかった。本願は高い効果を有する過酸化脂質生成抑制剤及び皮膚外用剤、特にニキビの予防改善に有効なアクネ用皮膚外用剤を提供することを課題とした。     The effect of suppressing the production of lipid peroxide by vitamin C or its derivative alone is insufficient, and an effect on acne and the like caused by the formation of lipid peroxide cannot be expected. This application made it the subject to provide the lipid peroxide production inhibitor and skin external preparation which have a high effect, especially the skin external preparation for acne effective in prevention and improvement of acne.

ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物を組み合わせて用いることにより、優れた過酸化脂質生成抑制剤及び皮膚外用剤、特にアクネ用皮膚外用剤を見出し、さらに緑茶抽出物を組み合わせて用いることにより、優れた過酸化脂質生成抑制剤及び皮膚外用剤、特にアクネ用皮膚外用剤を見出し、本発明を完成するに至った。     By using a combination of vitamin C or a derivative thereof and strawberry tea and / or black tea extract, an excellent lipid peroxide production inhibitor and an external preparation for skin, in particular, an external preparation for skin for acne, and further combining a green tea extract By using it, the present inventors have found an excellent lipid peroxide production inhibitor and a skin external preparation, in particular, an acne skin external preparation, and have completed the present invention.

本発明によれば、ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物、さらに緑茶抽出物を組み合わせて用いることにより、相乗的に優れた過酸化脂質抑制効果を発揮する過酸化脂質生成抑制剤及び皮膚外用剤、特に、ニキビの予防改善に有効なアクネ用皮膚外用剤を提供することができる。     According to the present invention, by using vitamin C or a derivative thereof in combination with strawberry tea and / or black tea extract, and further green tea extract, the production of lipid peroxide is suppressed in a synergistic manner. And an external preparation for skin, in particular, an external skin preparation for acne that is effective in preventing and improving acne.

図1は、ポルフィリン由来一重項酸素によるスクアレン過酸化物生成抑制作用の評価結果のグラフである。FIG. 1 is a graph showing an evaluation result of a squalene peroxide production inhibitory action by porphyrin-derived singlet oxygen.

本発明で用いるビタミンCまたはその誘導体としては特に限定されず、例えば、L−アスコルビン酸モノステアレート、L−アスコルビン酸モノパルミテート、L−アスコルビン酸モノオレエート等のアスコルビン酸モノ脂肪酸エステル類、L−アスコルビン酸モノリン酸エステル、L−アスコルビン酸−2−硫酸エステル等のアスコルビン酸モノエステル誘導体、L−アスコルビン酸ジステアレート、L−アスコルビン酸ジパルミテート、L−アスコルビン酸ジオレエート等のL−アスコルビン酸ジ脂肪酸エステル誘導体、L−アスコルビン酸トリステアレート、L−アスコルビン酸トリパルミテート、L−アスコルビン酸トリオレエート等のL−アスコルビン酸トリ脂肪酸エステル誘導体、L−アスコルビン酸トリリン酸エステル等のL−アスコルビン酸トリエステル誘導体等を挙げることができる。これらのビタミンCまたはその誘導体のうち、特に好ましいものは、L−アスコルビン酸またはL−アスコルビン酸リン酸エステル、およびこれらの塩である。     Vitamin C or a derivative thereof used in the present invention is not particularly limited. For example, ascorbic acid monofatty acid esters such as L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, L-ascorbic acid monooleate, L- Ascorbic acid monophosphate ester, L-ascorbic acid monoester derivative such as L-ascorbic acid-2-sulfate ester, L-ascorbic acid difatty acid ester derivative such as L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid dioleate L-ascorbic acid tristearate, L-ascorbic acid tripalmitate, L-ascorbic acid trifatty acid ester derivatives such as L-ascorbic acid trioleate, L-ascorbic acid triphosphate ester, etc. Ascorbic acid triester derivatives and the like. Among these vitamin C or derivatives thereof, L-ascorbic acid or L-ascorbic acid phosphate ester and salts thereof are particularly preferable.

本発明で用いる緑茶抽出物は、チャノキ(Thea sinensis Linne)の葉から製したもの(緑茶)から水、エタノール溶液、プロピレングリコール溶液またはグリセリン溶液にて抽出して得られる抽出物である。好ましくは、50%エタノールで抽出して得られる抽出物である。     The green tea extract used in the present invention is an extract obtained by extracting from tea leaves (Thea sinensis Linne) leaves (green tea) with water, ethanol solution, propylene glycol solution or glycerin solution. Preferably, it is an extract obtained by extraction with 50% ethanol.

本発明で用いる紅茶抽出物は、アッサムチャ(Thea sinensis Linne var. assamica Pierre)の葉より製したもの(紅茶)のエタノール溶液による抽出物を用いるのが好ましい。     As the black tea extract used in the present invention, it is preferable to use an extract of an ethanol solution of tea made from the leaves of Assamcha (Thea sinensis Linne var. Assamica Pierre).

本発明で用いる甜茶抽出物は、Rubus suavissimus の葉をしばらく熱湯に漬けたのち、葉を取り出して乾燥し、さらに加熱したものを熱水にて抽出して得られた成分を用いるのが好ましい。     It is preferable to use a component obtained by extracting the leaves of Rubus suavissimus in hot water for a while, taking out the leaves, drying them, and extracting the heated ones with hot water.

本発明で用いる緑茶、紅茶、甜茶の上記溶媒による抽出物は、そのままでも使用することができるが、一定期間そのまま静置して熟成させて用いてもよいし、濃縮、乾固した物を水や極性溶媒に再度溶解して使用することもできる。あるいは、これらの生理作用を損なわない範囲で、脱色、脱臭、脱塩等の精製処理や、カラムクロマトグラフィー等による分画処理を行った後に用いてもよい。植物および貝類の前記抽出物やその処理物および分画物は、各処理および分画後に凍結乾燥し、用時溶媒に溶解して用いることもできる。また、リポソーム等のベシクルやマイクロカプセル等に内包させて用いることもできる。     Extracts of the above-mentioned solvents for green tea, black tea, and green tea used in the present invention can be used as they are, but they may be left to stand for a certain period of time and used for aging. Alternatively, it can be dissolved again in a polar solvent. Alternatively, it may be used after performing purification treatment such as decolorization, deodorization and desalting, and fractionation treatment by column chromatography or the like within a range not impairing these physiological functions. The said extract of plant and shellfish, its processed material, and the fractionation thing can also be freeze-dried after each processing and fractionation, and can also be melt | dissolved and used for a use solvent. It can also be used by encapsulating in vesicles such as liposomes or microcapsules.

ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物、さらに緑茶抽出物を組み合わせて用いることにより、優れた過酸化脂質生成抑制剤として利用することができる。     By using a combination of vitamin C or a derivative thereof, strawberry tea and / or black tea extract, and further green tea extract, it can be used as an excellent lipid peroxide production inhibitor.

ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物、さらに緑茶抽出物を組み合わせて用いることにより、優れた皮膚外用剤として利用することができる。     By using a combination of vitamin C or a derivative thereof, strawberry tea and / or black tea extract, and further green tea extract, it can be used as an excellent external preparation for skin.

ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物、さらに緑茶抽出物を組み合わせて用いることにより、優れたニキビの予防改善に優れた効果を発揮するアクネ用皮膚外用剤として利用することができる。     It can be used as a skin external preparation for acne that exerts an excellent effect on prevention and improvement of excellent acne by using vitamin C or a derivative thereof in combination with strawberry tea and / or black tea extract and further green tea extract. .

ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物、さらに緑茶抽出物を組み合わせて用いることにより、ポルフィリンが発生する一重項酸素によるスクアレン過酸化物生成抑制作用を有し、優れた抗アクネ効果を発揮する。     By using a combination of vitamin C or a derivative thereof, strawberry tea and / or black tea extract, and further green tea extract, it has a squalene peroxide production-inhibiting action due to singlet oxygen generated by porphyrin, and has an excellent anti-acne effect Demonstrate.

ニキビ用組成物には、ビタミンCまたはその誘導体と、緑茶、紅茶、および甜茶抽出物の他に、その用途と必要に応じて、医薬品、医薬部外品、皮膚化粧料、毛髪用化粧料および洗浄料等に通常配合される任意の成分、例えば水、油性成分、保湿剤、粉体、色素、乳化剤、可溶化剤、ゲル化剤、洗浄剤、紫外線吸収剤、抗炎症剤、増粘剤、pH調整剤、キレート剤、薬剤(薬効成分)、香料、樹脂、防菌防かび剤、抗酸化剤、またはアルコール類等を適宜配合することができる。さらに、本発明の効果を損なわない範囲において、他の抗ニキビ剤あるいは他の植物抽出物との併用も可能である。     In addition to vitamin C or its derivatives and green tea, black tea, and strawberry tea extracts, acne compositions include pharmaceuticals, quasi drugs, skin cosmetics, hair cosmetics and Arbitrary ingredients that are usually blended in detergents, such as water, oily ingredients, moisturizers, powders, pigments, emulsifiers, solubilizers, gelling agents, detergents, UV absorbers, anti-inflammatory agents, thickeners , PH adjusters, chelating agents, drugs (medicinal ingredients), fragrances, resins, antibacterial and antifungal agents, antioxidants, alcohols, and the like can be appropriately blended. Furthermore, in the range which does not impair the effect of this invention, it can use together with another anti-acne agent or another plant extract.

ビタミンCまたはその誘導体の皮膚外用剤への配合量は、種類や目的等によって調整することができるが、効果や安定性などの点から、ビタミンCまたはその誘導体が全量に対して固形分換算で、好ましくは0.00001〜10.0質量%であり、より好ましくは0.0001〜5.0質量%であり、さらに好ましくは0.001〜5.0質量%であり、一層好ましくは0.001〜1.0質量%である。     The amount of vitamin C or its derivative added to the external preparation for skin can be adjusted depending on the type and purpose, but from the viewpoint of effect and stability, vitamin C or its derivative is converted to solid content with respect to the total amount. , Preferably 0.00001 to 10.0% by mass, more preferably 0.0001 to 5.0% by mass, still more preferably 0.001 to 5.0% by mass, and still more preferably 0.001. It is 001-1.0 mass%.

緑茶抽出物の皮膚外用剤への配合量は、種類や目的等によって調整することができるが、効果や安定性などの点から、それぞれ緑茶、紅茶、甜茶抽出物が全量に対して固形分換算で、好ましくは0.00001〜10.0質量%であり、より好ましくは0.0001〜5.0質量%であり、さらに好ましくは0.001〜5.0質量%であり、一層好ましくは0.001〜1.0質量%である。     The amount of green tea extract added to the external preparation for skin can be adjusted depending on the type and purpose, but from the viewpoint of effectiveness and stability, green tea, black tea, and strawberry tea extract are converted to solid content with respect to the total amount, respectively. Preferably, it is 0.00001-10.0 mass%, More preferably, it is 0.0001-5.0 mass%, More preferably, it is 0.001-5.0 mass%, More preferably, it is 0 0.001 to 1.0% by mass.

紅茶抽出物の皮膚外用剤への配合量は、種類や目的等によって調整することができるが、効果や安定性などの点から、それぞれ緑茶、紅茶、甜茶抽出物が全量に対して固形分換算で、好ましくは0.00001〜10.0質量%であり、より好ましくは0.0001〜5.0質量%であり、さらに好ましくは0.001〜5.0質量%であり、一層好ましくは0.001〜1.0質量%である。     The amount of black tea extract added to the external preparation for skin can be adjusted according to the type and purpose, but from the viewpoint of effectiveness and stability, green tea, black tea, and strawberry tea extract are converted to solid content with respect to the total amount, respectively. Preferably, it is 0.00001-10.0 mass%, More preferably, it is 0.0001-5.0 mass%, More preferably, it is 0.001-5.0 mass%, More preferably, it is 0 0.001 to 1.0% by mass.

甜茶抽出物の皮膚外用剤への配合量は、種類や目的等によって調整することができるが、効果や安定性などの点から、それぞれ緑茶、紅茶、甜茶抽出物が全量に対して固形分換算で、好ましくは0.00001〜10.0質量%であり、より好ましくは0.0001〜5.0質量%であり、さらに好ましくは0.001〜5.0質量%であり、一層好ましくは0.001〜1.0質量%である。     The amount of strawberry tea extract added to the external preparation for skin can be adjusted depending on the type and purpose, but from the viewpoint of effect and stability, green tea, black tea, and strawberry tea extract are converted to solid content with respect to the total amount, respectively. Preferably, it is 0.00001-10.0 mass%, More preferably, it is 0.0001-5.0 mass%, More preferably, it is 0.001-5.0 mass%, More preferably, it is 0 0.001 to 1.0% by mass.

以下にビタミンCまたはその誘導体と、緑茶、紅茶、および甜茶抽出物の調製例、抗アクネ効果を評価するための試験方法についてさらに詳細に説明するが、本発明の技術的範囲はこれらによってなんら限定されるものではない。     Hereinafter, preparation examples of vitamin C or a derivative thereof, green tea, black tea, and strawberry tea extract, and a test method for evaluating the anti-acne effect will be described in more detail. However, the technical scope of the present invention is limited by these. Is not to be done.

<ビタミンCまたはその誘導体>
ビタミンCまたはその誘導体として、市販されている試薬レベルのL−(+)−アスコルビン酸を用いた。
<Vitamin C or its derivative>
L-(+)-ascorbic acid with a commercially available reagent level was used as vitamin C or a derivative thereof.

<緑茶抽出物>
チャノキ(Thea sinensis Linne)の葉から製したもの(緑茶)から、50%エタノールで抽出して得られる抽出物である。
<Green tea extract>
It is an extract obtained by extracting with 50% ethanol from tea leaves (Thea sinensis Linne) leaves (green tea).

<紅茶抽出物>
アッサムチャ(Thea sinensis Linne var. assamica Pierre)の葉より製したもの(紅茶)のエタノール溶液による抽出液に、1,3−ブチレングリコール溶液を加えたものである。
<Black tea extract>
A 1,3-butylene glycol solution is added to an ethanol solution of a product made from the leaves of Assamcha (Thea sinensis Linne var. Assamica Pierre) (tea).

<甜茶抽出物>
Rubus suavissimus の葉をしばらく熱湯に漬けたのち、葉を取り出して乾燥し、さらに加熱したものを熱水にて抽出して得られた成分を50質量%の1,3−ブチレングリコール溶液に溶かしたものである。
<Sweet tea extract>
After immersing the leaves of Rubus suavissimus in boiling water for a while, the leaves were taken out, dried, and further heated and extracted with hot water. The components obtained were dissolved in 50% by mass of 1,3-butylene glycol solution. Is.

[実施例1]
<ポルフィリン由来一重項酸素によるスクアレン過酸化物生成抑制作用の評価>
メタノール:クロロホルム=1:1の混合液で調製したスクアレン溶液(30mM)500μLに、任意の有機溶媒で表1に示す濃度に調製したサンプル溶液500μLと、メタノール:クロロホルム=1:1の混合液で調製したヘマトポルフィリン溶液(15μM)500μLを添加し、よく混合した後、UVAを2mW/cmで10分間照射する。(これを反応溶液とする。)反応溶液40μLを別にサンプリングし、ヨウ化カリウム飽和溶液を5μL添加する。さらにクロロホルム:酢酸:エタノール=4:4:1の混合溶液を全量5mLとなるように添加する。30分間暗所で反応後、359nmの吸光度を測定した。ヘマトポルフィリン無添加の吸光度で補正後の試料無添加時の吸光度を(A)、試料添加時の吸光度を(B)とした時、ポルフィリン由来一重項酸素によるスクアレン過酸化物生成抑制率は次式に定義される。
抑制率(%)={(A)−(B)/(A)}×100
[Example 1]
<Evaluation of squalene peroxide production inhibitory action by porphyrin-derived singlet oxygen>
In 500 μL of a squalene solution (30 mM) prepared in a mixture of methanol: chloroform = 1: 1, 500 μL of a sample solution prepared to the concentration shown in Table 1 with any organic solvent, and in a mixture of methanol: chloroform = 1: 1 After adding 500 μL of the prepared hematoporphyrin solution (15 μM) and mixing well, UVA is irradiated at 2 mW / cm 2 for 10 minutes. (This is used as a reaction solution.) 40 μL of the reaction solution is sampled separately, and 5 μL of a saturated potassium iodide solution is added. Further, a mixed solution of chloroform: acetic acid: ethanol = 4: 4: 1 is added to a total volume of 5 mL. After reacting in the dark for 30 minutes, the absorbance at 359 nm was measured. When the absorbance after addition of the sample after correction with the absorbance without hematoporphyrin is (A) and the absorbance when the sample is added is (B), the inhibition rate of squalene peroxide production by porphyrin-derived singlet oxygen is Defined in
Inhibition rate (%) = {(A) − (B) / (A)} × 100

その結果を表1および図1に示す。     The results are shown in Table 1 and FIG.

Figure 2011057578
Figure 2011057578

表1の結果から、ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物、さらに緑茶抽出物を組み合わせて用いることにより、ポルフィリン由来の一重項酸素によるスクアレン過酸化物生成抑制作用を示し、相乗的に優れた抗アクネ効果を有することを見出した。     From the results shown in Table 1, by using a combination of vitamin C or a derivative thereof, strawberry tea and / or black tea extract, and further green tea extract, squalene peroxide production-inhibiting action by porphyrin-derived singlet oxygen is shown and synergistic. It was found that it has an excellent anti-acne effect.

次に本発明の他の皮膚外用剤について処方例を示す。     Next, a prescription example is shown about the other external preparation for skin of this invention.

[実施例2]
アクネ用皮膚外用剤(ローションタイプ)
(1)エタノール 5.00(質量%)
(2)パラオキシ安息香酸メチル 0.02
(3)濃グリセリン 3.00
(4)1,3−ブチレングリコール 1.00
(5)アスコルビン酸誘導体 0.01
(6)緑茶抽出物 0.01
(7)紅茶抽出物 0.01
(8)甜茶抽出物 0.01
(9)精製水 100.00とする残部
製法:(1)、(2)、(6)、および(7)を均一に溶解しアルコール相とする。これを、あらかじめ(9)に(3)〜(5)、および(8)を添加して均一にした水相に撹拌しながら均一に混合する。
[Example 2]
Skin preparation for acne (lotion type)
(1) Ethanol 5.00 (mass%)
(2) Methyl paraoxybenzoate 0.02
(3) Concentrated glycerin 3.00
(4) 1,3-butylene glycol 1.00
(5) Ascorbic acid derivative 0.01
(6) Green tea extract 0.01
(7) Black tea extract 0.01
(8) Green tea extract 0.01
(9) Purified water 100.00 The remaining manufacturing method: (1), (2), (6), and (7) are uniformly dissolved to obtain an alcohol phase. The mixture is uniformly mixed with stirring in an aqueous phase obtained by adding (3) to (5) and (8) to (9) in advance.

[実施例3]
アクネ用皮膚外用剤(乳液タイプ)
(1)トリ−2−エチルヘキサン酸グリセリル 8.00(質量%)
(2)自己乳化型モノステアリン酸グリセリン 2.50
(3)ベヘニルアルコール 0.50
(4)濃グリセリン 5.00
(5)精製水 100.00とする残部
(6)キサンタンガム(1重量%水溶液) 20.00
(7)アスコルビン酸誘導体 0.01
(8)緑茶抽出物 0.01
(9)紅茶抽出物 0.01
(10)甜茶抽出物 0.01
(11)エタノール 4.00
(12)パラオキシ安息香酸メチル 0.15
製法:(1)〜(3)の油相と(4)〜(6)の水相をそれぞれ80℃まで加熱溶解する。両相を混合し、ホモミキサーを用いて均一に乳化する。45℃まで冷却後(7)、(10)の水相と(8)、(9)、(11)、および(12)を併せたアルコール相を各々加え、均一に撹拌する。
[Example 3]
Acne skin external preparation (milky lotion type)
(1) Glyceryl tri-2-ethylhexanoate 8.00 (mass%)
(2) Self-emulsifying glyceryl monostearate 2.50
(3) Behenyl alcohol 0.50
(4) Concentrated glycerin 5.00
(5) Purified water 100.00 The remainder (6) Xanthan gum (1 wt% aqueous solution) 20.00
(7) Ascorbic acid derivative 0.01
(8) Green tea extract 0.01
(9) Black tea extract 0.01
(10) Green tea extract 0.01
(11) Ethanol 4.00
(12) Methyl paraoxybenzoate 0.15
Production method: The oil phases (1) to (3) and the aqueous phases (4) to (6) are dissolved by heating up to 80 ° C., respectively. Both phases are mixed and uniformly emulsified using a homomixer. After cooling to 45 ° C., the aqueous phase (7) and (10) and the alcohol phase combined with (8), (9), (11), and (12) are added and stirred uniformly.

[実施例4]
アクネ用皮膚外用剤(クリームタイプ)
(1)スクワラン 10.00(質量%)
(2)ステアリン酸 2.00
(3)水素添加パーム核油 0.50
(4)水素添加大豆リン脂質 0.10
(5)セタノール 3.60
(6)親油型モノステアリン酸グリセリン 2.00
(7)グリセリン 10.00
(8)パラオキシ安息香酸メチル 0.10
(9)1重量%カルボキシビニルポリマー水溶液 15.00
(10)精製水 100.00とする残部
(11)10重量%L−アルギニン水溶液 3.00
(12)アスコルビン酸誘導体 0.01
(13)緑茶抽出物 0.01
(14)紅茶抽出物 0.01
(15)甜茶抽出物 0.01
製法:(1)〜(6)の油相成分を加熱溶解し、80℃とする。一方(7)〜(10)を加熱溶解し、80℃とする。これに前記油相を撹拌しながら加えたあと、(11)を加えて、ホモジナイザーにより均一に乳化し45℃まで冷却後(12)〜(15)を加え、均一に撹拌する。
[Example 4]
Skin preparation for acne (cream type)
(1) Squalane 10.00 (mass%)
(2) Stearic acid 2.00
(3) Hydrogenated palm kernel oil 0.50
(4) Hydrogenated soybean phospholipid 0.10
(5) Cetanol 3.60
(6) Lipophilic glyceryl monostearate 2.00
(7) Glycerin 10.00
(8) Methyl paraoxybenzoate 0.10
(9) 1% by weight carboxyvinyl polymer aqueous solution 15.00
(10) Purified water 100.00 The remainder (11) 10 wt% L-arginine aqueous solution 3.00
(12) Ascorbic acid derivative 0.01
(13) Green tea extract 0.01
(14) Black tea extract 0.01
(15) Green tea extract 0.01
Production method: The oil phase components (1) to (6) are dissolved by heating to 80 ° C. On the other hand, (7) to (10) are dissolved by heating to 80 ° C. To this is added the oil phase with stirring, then (11) is added, and the mixture is uniformly emulsified with a homogenizer, cooled to 45 ° C., (12) to (15) are added, and the mixture is stirred uniformly.

[実施例5]
クレンジング料
(1)スクワラン 81.0(質量%)
(2)イソステアリン酸ポリオキシエチレングリセリル 15.0
(3)精製水 100とする残部
(4)アスコルビン酸誘導体 0.01
(5)緑茶抽出物 0.01
(6)紅茶抽出物 0.01
(7)甜茶抽出物 0.01
製法:(1)と(2)を均一に溶解する。これに、(3)〜(7)を順次加え、均一に混合する。
[Example 5]
Cleansing fee (1) Squalane 81.0 (mass%)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Purified water 100 (4) Ascorbic acid derivative 0.01
(5) Green tea extract 0.01
(6) Black tea extract 0.01
(7) Green tea extract 0.01
Manufacturing method: (1) and (2) are uniformly dissolved. To this, (3) to (7) are sequentially added and mixed uniformly.

[実施例6]
洗顔フォーム
(1)ステアリン酸 16.0(質量%)
(2)ミリスチン酸 16.0
(3)親油型モノステアリン酸グリセリン 2.0
(4)グリセリン 25.0
(5)水酸化ナトリウム 7.5
(6)ヤシ油脂肪酸アミドプロピルベタイン 1.0
(7)精製水 100とする残部
(8)アスコルビン酸誘導体 0.01
(9)緑茶抽出物 0.01
(10)紅茶抽出物 0.01
(11)甜茶抽出物 0.01
製法:(1)〜(4)の油相成分を80℃にて加熱溶解する。一方(5)〜(8)の水相成分を80℃にて加熱溶解し、油相成分と均一に混合撹拌する。冷却後40℃にて(9)〜(11)を順次加え、均一に混合する。
[Example 6]
Facial cleansing foam (1) Stearic acid 16.0 (mass%)
(2) Myristic acid 16.0
(3) Lipophilic glyceryl monostearate 2.0
(4) Glycerin 25.0
(5) Sodium hydroxide 7.5
(6) Palm oil fatty acid amidopropyl betaine 1.0
(7) The balance which makes 100 purified water (8) Ascorbic acid derivative 0.01
(9) Green tea extract 0.01
(10) Black tea extract 0.01
(11) Green tea extract 0.01
Production method: The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (5) to (8) are heated and dissolved at 80 ° C., and mixed and stirred uniformly with the oil phase component. After cooling, (9) to (11) are sequentially added at 40 ° C. and mixed uniformly.

パック
(1)精製水 100とする残部(質量%)
(2)ポリビニルアルコール 12.0
(3)エタノール 17.0
(4)グリセリン 9.0
(5)ポリエチレングリコール(平均分子量1000) 2.0
(6)アスコルビン酸誘導体 0.01
(7)緑茶抽出物 0.01
(8)紅茶抽出物 0.01
(9)甜茶抽出物 0.01
(10)香料 0.1
製法:(2)と(3)を混合し、80℃に加温した後、80℃に加温した(1)に溶解する。均一に溶解した後、(4)と(5)を加え、攪拌しながら冷却する。40℃にて(6)〜(10)を順次加え、均一に混合する。
Pack (1) Remainder water (100%)
(2) Polyvinyl alcohol 12.0
(3) Ethanol 17.0
(4) Glycerin 9.0
(5) Polyethylene glycol (average molecular weight 1000) 2.0
(6) Ascorbic acid derivative 0.01
(7) Green tea extract 0.01
(8) Black tea extract 0.01
(9) Green tea extract 0.01
(10) Fragrance 0.1
Production method: (2) and (3) are mixed, heated to 80 ° C, and then dissolved in (1) heated to 80 ° C. After evenly dissolving, add (4) and (5) and cool with stirring. (6) to (10) are sequentially added at 40 ° C. and mixed uniformly.

ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物、さらに緑茶抽出物を組み合わせて用いることにより、相乗的に優れた過酸化脂質抑制効果を発揮する過酸化脂質生成抑制剤及び皮膚外用剤、特にニキビの予防改善に有効なアクネ用皮膚外用剤として有用である。     By using vitamin C or a derivative thereof in combination with strawberry tea and / or black tea extract, and further green tea extract, a lipid peroxide production inhibitor and an external preparation for skin that exhibit a synergistically excellent lipid peroxide inhibitory effect, It is particularly useful as a skin external preparation for acne that is effective in preventing and improving acne.

Claims (5)

ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物を含有することを特徴とする、過酸化脂質生成抑制剤。   A lipid peroxide production inhibitor characterized by containing vitamin C or a derivative thereof and strawberry tea and / or black tea extract. さらに、緑茶抽出物を含有することを特徴とする、請求項1に記載の過酸化脂質生成抑制剤。   Furthermore, the lipid peroxide production inhibitor of Claim 1 containing a green tea extract. ビタミンCまたはその誘導体と、甜茶および/または紅茶抽出物を含有することを特徴とする、皮膚外用剤。   An external preparation for skin characterized by containing vitamin C or a derivative thereof and strawberry tea and / or black tea extract. さらに、緑茶抽出物を含有することを特徴とする、請求項1に記載の皮膚外用剤。   Furthermore, the skin external preparation of Claim 1 containing a green tea extract. アクネ用である請求項3または4に記載の皮膚外用剤。   The skin external preparation according to claim 3 or 4, which is for acne.
JP2009206601A 2009-09-08 2009-09-08 Peroxide lipid inhibitor and skin external preparation Pending JP2011057578A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009206601A JP2011057578A (en) 2009-09-08 2009-09-08 Peroxide lipid inhibitor and skin external preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009206601A JP2011057578A (en) 2009-09-08 2009-09-08 Peroxide lipid inhibitor and skin external preparation

Publications (1)

Publication Number Publication Date
JP2011057578A true JP2011057578A (en) 2011-03-24

Family

ID=43945651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009206601A Pending JP2011057578A (en) 2009-09-08 2009-09-08 Peroxide lipid inhibitor and skin external preparation

Country Status (1)

Country Link
JP (1) JP2011057578A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017510596A (en) * 2014-04-09 2017-04-13 ディグニティ サイエンシス リミテッド Composition for treating skin conditions

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6127910A (en) * 1984-07-19 1986-02-07 Kao Corp Cosmetic
JPH0144234B2 (en) * 1983-05-30 1989-09-26 Mitsui Norin Kk
JPH02243632A (en) * 1989-03-16 1990-09-27 Ichimaru Pharcos Co Ltd Peroxide lipid formation inhibitor comprising vegetable oil extract
JPH0881325A (en) * 1994-09-09 1996-03-26 Kose Corp Cosmetic
JPH09110628A (en) * 1995-09-19 1997-04-28 L'oreal Sa Composition for make-up and/or dermatology containing ascorbic acid as active agent for treating seborrhea
JPH111820A (en) * 1997-06-09 1999-01-06 Fuji Spinning Co Ltd Modified cellulosic regenerated fiber and its production
JPH11279069A (en) * 1998-03-27 1999-10-12 Ichimaru Pharcos Co Ltd Active oxygen eliminating agent
JP2000327550A (en) * 1999-05-19 2000-11-28 Kose Corp Skin preparation for external use
JP2001122757A (en) * 1999-10-22 2001-05-08 Naris Cosmetics Co Ltd Active oxygen scavenger, antioxidant and cosmetic
JP2001181173A (en) * 1999-12-27 2001-07-03 Kose Corp Bleaching preparation for external use
JP2002128688A (en) * 2000-10-20 2002-05-09 Arsoa Honsya Corp Active oxygen scavenging composition
JP2003306446A (en) * 2002-02-14 2003-10-28 Fancl Corp Skin ageing-preventing agent and/or pimple-improving agent kit
JP2004010505A (en) * 2002-06-04 2004-01-15 Fancl Corp Cosmetic
JP2004041186A (en) * 2002-05-17 2004-02-12 Kao Corp Bottled black tea drink
JP2005139147A (en) * 2003-11-10 2005-06-02 Fine Foods Kyoto:Kk Water-soluble type skin lotion, skin coating agent and bathing agent each containing tea polyphenol as main agent
JP2006327981A (en) * 2005-05-26 2006-12-07 Aspac Kigyo Kk Composition for producing skin care pack agent and skin care pack agent containing the same
JP2007269677A (en) * 2006-03-31 2007-10-18 Mitsui Norin Co Ltd Glycosylated hemoglobin elevation inhibitor
JP2008088075A (en) * 2006-09-29 2008-04-17 Kose Corp Profilaggrin/filaggrin production promoter, epidermal keratinocyte proliferation promoter, skin care preparation for normalizing epidermis/horny cell layer, profilaggrin/filaggrin production-promoting method and epidermal keratinocyte proliferation-promoting method
JP2008201772A (en) * 2007-01-26 2008-09-04 Shiseido Co Ltd Anti-wrinkle agent and adam inhibitor

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0144234B2 (en) * 1983-05-30 1989-09-26 Mitsui Norin Kk
JPS6127910A (en) * 1984-07-19 1986-02-07 Kao Corp Cosmetic
JPH02243632A (en) * 1989-03-16 1990-09-27 Ichimaru Pharcos Co Ltd Peroxide lipid formation inhibitor comprising vegetable oil extract
JPH0881325A (en) * 1994-09-09 1996-03-26 Kose Corp Cosmetic
JPH09110628A (en) * 1995-09-19 1997-04-28 L'oreal Sa Composition for make-up and/or dermatology containing ascorbic acid as active agent for treating seborrhea
JPH111820A (en) * 1997-06-09 1999-01-06 Fuji Spinning Co Ltd Modified cellulosic regenerated fiber and its production
JPH11279069A (en) * 1998-03-27 1999-10-12 Ichimaru Pharcos Co Ltd Active oxygen eliminating agent
JP2000327550A (en) * 1999-05-19 2000-11-28 Kose Corp Skin preparation for external use
JP2001122757A (en) * 1999-10-22 2001-05-08 Naris Cosmetics Co Ltd Active oxygen scavenger, antioxidant and cosmetic
JP2001181173A (en) * 1999-12-27 2001-07-03 Kose Corp Bleaching preparation for external use
JP2002128688A (en) * 2000-10-20 2002-05-09 Arsoa Honsya Corp Active oxygen scavenging composition
JP2003306446A (en) * 2002-02-14 2003-10-28 Fancl Corp Skin ageing-preventing agent and/or pimple-improving agent kit
JP2004041186A (en) * 2002-05-17 2004-02-12 Kao Corp Bottled black tea drink
JP2004010505A (en) * 2002-06-04 2004-01-15 Fancl Corp Cosmetic
JP2005139147A (en) * 2003-11-10 2005-06-02 Fine Foods Kyoto:Kk Water-soluble type skin lotion, skin coating agent and bathing agent each containing tea polyphenol as main agent
JP2006327981A (en) * 2005-05-26 2006-12-07 Aspac Kigyo Kk Composition for producing skin care pack agent and skin care pack agent containing the same
JP2007269677A (en) * 2006-03-31 2007-10-18 Mitsui Norin Co Ltd Glycosylated hemoglobin elevation inhibitor
JP2008088075A (en) * 2006-09-29 2008-04-17 Kose Corp Profilaggrin/filaggrin production promoter, epidermal keratinocyte proliferation promoter, skin care preparation for normalizing epidermis/horny cell layer, profilaggrin/filaggrin production-promoting method and epidermal keratinocyte proliferation-promoting method
JP2008201772A (en) * 2007-01-26 2008-09-04 Shiseido Co Ltd Anti-wrinkle agent and adam inhibitor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
機能性化粧品IV,株式会社シーエムシー出版,2006年6月30日,第1刷、64-71頁,奥付, JPN6013016800, ISSN: 0002503762 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017510596A (en) * 2014-04-09 2017-04-13 ディグニティ サイエンシス リミテッド Composition for treating skin conditions

Similar Documents

Publication Publication Date Title
US20180021247A1 (en) Topical compositions comprising hydroxy acids and cannabinoids for skin care
CN107412031B (en) Skin external composition containing hesperetin
JP2000229832A (en) Skin lotion
JP2005082522A (en) Bleaching cosmetic
CA2819796A1 (en) Extract of the above-ground portions of gynandropsis gynandra or cleome gynandra, and cosmetic, dermatological or pharmaceutical compositions including same
CN107440949A (en) Composition and its application comprising extractive of perilla and Radix Arnebiae extract
JP2000247864A (en) Cosmetic composition
CN106420516A (en) Red onion extract containing skin-care product and application thereof
TWI757246B (en) Composition for topical application comprising dimethyl isosorbide, a polyol, and a phenolic or polyphenolic antioxidant
JP2008184416A (en) External preparation for skin, cell activation agent and antioxidation agent
JP2007045733A (en) Hyaluronidase inhibitor
JP2008247786A (en) External preparation for skin
KR101367703B1 (en) Composition of cosmetic and treating skin disease
JP2011057578A (en) Peroxide lipid inhibitor and skin external preparation
JP5072300B2 (en) Cyclic AMP phosphodiesterase inhibitor
JP2008094734A (en) Antiwrinkle agent and external preparation for skin
JP4716497B2 (en) External preparation for skin and hyaluronidase inhibitor
JP2001048740A (en) Blood circulation accelerator
JP2001322990A (en) Active oxygen scavenger and composition containing the same for erasing active oxygen
KR20160016382A (en) Skin External Composition Comprising the Niaouli
JP2002068956A (en) Skin cosmetic
JP2007008818A (en) External preparation for skin
JP2002234828A (en) Skin whitening cosmetic preparation
US20180362456A1 (en) New compounds with antioxidant and antiaging activity
KR102496723B1 (en) A composition for prevention, improvement or treatment of skin diseases containing a Ophiopogonin-D

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110823

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130416

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140204